Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women’s Health Initiative memory study: a randomized clinical trial

Women's Health ◽

Postmenopausal Women ◽

Randomized Clinical Trial ◽

Health Initiative ◽

Estrogen Plus Progestin ◽

The Women’S Health Initiative ◽

Incidence Of Dementia

The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health outcomes in the Women's Health Initiative Calcium and Vitamin D randomized clinical trial

Menopause ◽

10.1097/gme.0000000000001667 ◽

2020 ◽

Vol 27 (11) ◽

pp. 1265-1273

Author(s):

Matthew Nudy ◽

Xuezhi Jiang ◽

Aaron K. Aragaki ◽

JoAnn E. Manson ◽

Aladdin H. Shadyab ◽

...

Keyword(s):

Clinical Trial ◽

Vitamin D ◽

Health Outcomes ◽

Women's Health ◽

Postmenopausal Women ◽

Randomized Clinical Trial ◽

Menopausal Symptoms ◽

Vasomotor Symptoms ◽

Health Initiative ◽

Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women. The Women???s Health Initiative Memory Study: A Randomized, Controlled Trial

Obstetrical & Gynecological Survey ◽

10.1097/01.ogx.0000089954.22841.3b ◽

2003 ◽

Vol 58 (10) ◽

pp. 675-677 ◽

Cited By ~ 1

Author(s):

Sally A. Shumaker ◽

Claudine Legault ◽

Stephen R. Rapp ◽

Leon Thal ◽

Robert B. Wallace ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Cognitive Impairment ◽

Postmenopausal Women ◽

Controlled Trial ◽

Health Initiative ◽

Randomized Controlled ◽

Estrogen Plus Progestin ◽

Incidence Of Dementia

P4-011: A CANDIDATE GENE STUDY OF GENETIC RISK FOR DEMENTIA AND MILD COGNITIVE IMPAIRMENT (MCI) IN WOMEN AGED >65 YEARS: RESULTS FROM THE WOMEN's HEALTH INITIATIVE MEMORY STUDY (WHIMS)

10.1016/j.jalz.2014.05.1525 ◽

2014 ◽

Vol 10 ◽

pp. P787-P788

Author(s):

Ira Driscoll ◽

Beverly M. Snively ◽

Mark A. Espeland ◽

Sally A. Shumaker ◽

Stephen R. Rapp ◽

...

Keyword(s):

Cognitive Impairment ◽

Candidate Gene ◽

Women's Health ◽

Genetic Risk ◽

Candidate Gene Study ◽

Health Initiative ◽

Gene Study ◽

P-125: Serum alpha tocopherol and incident amnestic mild cognitive impairment (A-MCI): The cognitive change in women (CCW) ancillary study to the women's health initiative (WHI)

10.1016/j.jalz.2007.04.189 ◽

2007 ◽

Vol 3 (3S_Part_2) ◽

pp. S138-S139

Author(s):

Julie E. Dunn ◽

Brian J. Harty ◽

Anne M. Stoddard ◽

Rebecca A. Gavett ◽

Sandra Weintraub

Keyword(s):

Cognitive Impairment ◽

Women's Health ◽

Cognitive Change ◽

Amnestic Mild Cognitive Impairment ◽

Alpha Tocopherol ◽

Health Initiative ◽

Ancillary Study ◽

Breast cancer after stopping estrogen plus progestin in postmenopausal women in the women's health initiative.

10.1158/0008-5472.sabcs-64 ◽

2009 ◽

Author(s):

RT Chlebowski ◽

L Kuller ◽

G Anderson ◽

J Mason ◽

R Schenken ◽

...

Keyword(s):

Breast Cancer ◽

Women’S Health ◽

Women's Health ◽

Postmenopausal Women ◽

Health Initiative ◽

Estrogen Plus Progestin ◽

P4-632: BASELINE COMPOSITION OF MACRONUTRIENTS IS ASSOCIATED WITH RISK OF MILD COGNITIVE IMPAIRMENT OR DEMENTIA: RESULTS FROM THE WOMEN'S HEALTH INITIATIVE MEMORY STUDY (WHIMS)

10.1016/j.jalz.2019.08.181 ◽

2019 ◽

Vol 15 ◽

pp. P1570-P1570

Author(s):

Xiaoyan Iris Leng ◽

Martha E. Payne ◽

Stephen R. Rapp ◽

Mara Vitolins

Keyword(s):

Cognitive Impairment ◽

Women’S Health ◽

Women's Health ◽

Health Initiative ◽

The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline

Clinical Trials ◽

10.1191/1740774504cn040oa ◽

2004 ◽

Vol 1 (5) ◽

pp. 440-450 ◽

Cited By ~ 62

Author(s):

Susan M Resnick ◽

Laura H Cokerb ◽

Pauline M Makia ◽

Stephen R Rapp ◽

Mark A Espeland ◽

...

Keyword(s):

Clinical Trial ◽

Cognitive Decline ◽

Hormone Therapy ◽

Women's Health ◽

Randomized Clinical Trial ◽

Cognitive Aging ◽

Health Initiative ◽

Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women’s Health Initiative Randomized Trial

Obstetrical & Gynecological Survey ◽

10.1097/01.ogx.0000093674.44946.d6 ◽

2003 ◽

Vol 58 (11) ◽

pp. 735-737

Author(s):

Rowan T. Chlebowski ◽

Susan L. Hendrix ◽

Robert D. Langer ◽

Marcia L. Stefanick ◽

Margery Gass ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Women’S Health ◽

Women's Health ◽

Postmenopausal Women ◽

Health Initiative ◽

Estrogen Plus Progestin ◽

Clonal Hematopoiesis of indeterminate potential and the risk of mild cognitive impairment or probable dementia in the Women’s Health Initiative Memory Study

10.1002/alz.039121 ◽

2020 ◽

Vol 16 (S10) ◽

Author(s):

Kathleen M. Hayden ◽

Xiaoyan Iris Leng ◽

JoAnn E. Manson ◽

Pinkal Desai ◽

Jacob Kitzman ◽

...

Keyword(s):

Cognitive Impairment ◽

Women’S Health ◽

Women's Health ◽

Clonal Hematopoiesis ◽

Health Initiative ◽

Risks and benefits of estrogen plus progestin in healthy postmenopausal women. principal results from the women’s health initiative randomized controlled trial

ACC Current Journal Review ◽

10.1016/s1062-1458(02)00919-4 ◽

2002 ◽

Vol 11 (6) ◽

pp. 38-39 ◽

Cited By ~ 2

Keyword(s):

Randomized Controlled Trial ◽

Women's Health ◽

Postmenopausal Women ◽

Controlled Trial ◽

Health Initiative ◽

Randomized Controlled ◽

Risks And Benefits ◽

Estrogen Plus Progestin ◽